| 1 |
Cutliffe AL, Mckenna SL, Chandrashekar DS, Ng A, Devonshire G, Fitzgerald RC, O’donovan TR, Mackrill JJ. Alterations in the Ca2+ toolkit in oesophageal adenocarcinoma. Exploration of Targeted Anti-tumor Therapy 2021;2. [DOI: 10.37349/etat.2021.00063] [Reference Citation Analysis]
|
| 2 |
Liu X, Yao X, Tsang SY. Post-Translational Modification and Natural Mutation of TRPC Channels. Cells 2020;9:E135. [PMID: 31936014 DOI: 10.3390/cells9010135] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 3 |
Ramirez GA, Coletto LA, Bozzolo EP, Citterio L, Delli Carpini S, Zagato L, Rovere-Querini P, Lanzani C, Manunta P, Manfredi AA, Sciorati C. The TRPC6 intronic polymorphism, associated with the risk of neurological disorders in systemic lupus erythematous, influences immune cell function. J Neuroimmunol 2018;325:43-53. [PMID: 30384327 DOI: 10.1016/j.jneuroim.2018.10.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 4 |
Yuan F, Cao X, Zhang Y, Chen L, Huang T, Li Z, Cai Y. Identification of Novel Lung Cancer Driver Genes Connecting Different Omics Levels With a Heat Diffusion Algorithm. Front Cell Dev Biol 2022;10:825272. [DOI: 10.3389/fcell.2022.825272] [Reference Citation Analysis]
|
| 5 |
Elzamzamy OM, Penner R, Hazlehurst LA. The Role of TRPC1 in Modulating Cancer Progression. Cells 2020;9:E388. [PMID: 32046188 DOI: 10.3390/cells9020388] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 6 |
Jiang Y, Zhou Y, Peng G, Tian H, Pan D, Liu L, Yang X, Li C, Li W, Chen L, Ran P, Dai A. Two-pore channels mediated receptor-operated Ca2+ entry in pulmonary artery smooth muscle cells in response to hypoxia. Int J Biochem Cell Biol 2018;97:28-35. [PMID: 29355755 DOI: 10.1016/j.biocel.2018.01.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Bai Y, Liu Y, Su Z, Ma Y, Ren C, Zhao R, Ji H. Gene editing as a promising approach for respiratory diseases. J Med Genet 2018;55:143-9. [DOI: 10.1136/jmedgenet-2017-104960] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Hutchings CJ, Colussi P, Clark TG. Ion channels as therapeutic antibody targets. MAbs 2019;11:265-96. [PMID: 30526315 DOI: 10.1080/19420862.2018.1548232] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 9 |
Zhang L, Bing S, Dong M, Lu X, Xiong Y. Targeting ion channels for the treatment of lung cancer. Biochim Biophys Acta Rev Cancer 2021;1876:188629. [PMID: 34610420 DOI: 10.1016/j.bbcan.2021.188629] [Reference Citation Analysis]
|
| 10 |
Rathkolb B, Howaldt M, Krebs S, Prückl P, Sauer S, Hrabě de Angelis M, Aigner B. Distinct Morphological and Behavioural Alterations in ENU-Induced Heterozygous Trpc7K810Stop Mutant Mice. Genes (Basel) 2021;12:1732. [PMID: 34828338 DOI: 10.3390/genes12111732] [Reference Citation Analysis]
|
